MAG200

N/A

Report date: 2024/07/26 10:01:30

Base Information

Drug NameMAG200
Drug Alias NameAllogeneic human adipose-derived mesenchymal stem cells (Magellan)MAG200MAG-200
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsOsteoarthritis, Knee
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesMagellan Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesMagellan Biosciences Inc
Inactive CompaniesN/A
Active IndicationsOsteoarthritis, Knee
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A